Solution Structure of Fk506 Binding Domain (fkbd) of Plasmodium Falciparum Fk506 Binding Protein 35 (Pffkbp35)
Cong Bao Kang,Hong Ye,Hye Rim Yoon,Ho Sup Yoon
DOI: https://doi.org/10.1002/prot.21623
2007-01-01
Abstract:Plasmodium falciparum is the most lethal pathogen among four species of Plasmodium that infect human beings.1 The immunosuppressive drug FK506 shows an antimalarial effect,2 suggesting that the parasite may contain a potential FK506 binding protein (FKBP) as the molecular target of the drug. Database analysis revealed the presence of a putative peptidylprolyl cis-trans isomerase (PPIase) (Swiss-Prot/TremBL ID Q8I4V_PLAF7) in Plasmodium falciparum. Recent studies have named it Plasmodium falciparum FKBP35 (PfFKBP35; GeneBank accession no. AAN36539) as a member of the FKBP family in the parasite.3, 4 PfFKBP35 shows a high similarity to FKBP12 in the catalytic core domain [40% sequence identity, Fig. 1(A)], whereas the overall structural architecture resembles the multiple tetratricopeptide repeat-containing FKBP family including FKBP38, FKBP51, and FKBP52.7 NMR structure of FKBD of PfFKBP35. A: Sequence alignment of FKBD of PfFKBP35 (AAN36539) and FKBP12 (A35780). Protein sequence alignment was generated by Vector NTI Align X (Informax). Based on three-dimensional structure of FKBP/FK506,5 residues in the active pocket for binding FK506 are indicated by open reverse triangles, and those which are involved in interaction with FK506 through hydrogen bonding are indicated by filled circles. NCBI protein data base accession number is indicated in parenthesis. The identical residues and residues with conservative changes are shown in orange and green, respectively. B: Backbone ensemble of 20 conformers with lowest energy is shown superposed. Ribbon drawings of FKBD of PfFKBP35 (C) and FKBP12 (PDB: 1FKS) (D) are displayed, respectively. E: An overlay of the backbone heavy atom trace (N, C ′,C α) of the NMR structures of FKBP12 (Red) and FKBD of PfFKBP35 (Blue) is shown. The Figures (A–E) were generated using the program MOLMOL.6 FKBP family, which is a part of a larger superfamily of immunophilins exerting roles as chaperones and possessing PPIase, plays important roles in several cellular processes including protein folding and suppressing T-cell activation upon binding the immunosuppressive ligands.8 Currently, little is know about how the growth of the parasite is inhibited by FK506. To better understand the biological function of PfFKBP35 and also provide a basis of the molecular interaction between PfFKBP35 and the ligand, in this study, we have determined the solution structure of the core isomerase domain PfFKBP35 (referred hereafter as FKBD). The structure shows the similar folds as seen in the other FKBP family proteins. Differences were seen in the regions of β3/4 and β5/6 loops, which are important for ligand-binding and PPIase activities. Ni2+– nitriloacetic acid (NTA) resin was purchased from Qiagen (Hilden, Germany). Protein molecular weight marker was from Bio-Rad Laboratories (Hercules, CA). HiPrep 26/60 Sephacryl S-200 column was from Amersham Biosciences (Buckinghamshire, UK). Chemicals were purchased from Sigma–Aldrich (St. Louis, MO). Escherichia coli BL21 (DE3) cells and kanamycin were from Invitrogen (Carlsbad, CA). The vector pET29b was from Novagen (Madison, WI). Isopropyl-thio-β-D-galactopyranoside (IPTG) was from Promega (Madison, WI). The DNA fragment encoding the FKBD (M1 to E127) of PfFKBP35 was obtained from the genomic DNA of Plasmodium falciparum 3D7 (A kind gift from Dr. Peter Preiser) by polymerase chain reaction. The amplified DNA fragment was cloned into the plasmid pET29 with Nde I and Xho I restriction enzymes. The recombinant plasmids harboring the target gene was transformed into E. coli BL21(DE3) host cells and followed by protein expression. The resulting construct contained eight nonnative residues at the C-terminus (LEHHHHHH). The recombinant protein was purified by Ni2+-NTA affinity purification and followed by the gel filtration as previously described.9 The 15N and 15N/13C uniformly labeled proteins were prepared by growing the cells in the M9 medium supplied with 1 g/L of 15NH4Cl or 1 g/L of 15NH4Cl and 1 g/L of 13C-glucose.10 The purified NMR samples (∼0.5 mM) were dissolved in 90% H2O/10% D2O containing 20 mM Na-PO4 (pH 6.8), 20 mM NaCl, 1 mM DTT, 0.01% NaN3. NMR spectra were acquired on a Bruker AV600 (equipped with a cryoprobe) spectrometer at 298 K. Spectra were processed with NMRPipe11 and analyzed using NMRview.12 Backbone resonance assignments were achieved by using data from HNCA, HN(CO)CA, HNCO, HNCACB, CBCACONH, and 3D 15N-HSQC-NOESY.13 The aliphatic side-chain resonance assignments were made from HCCH-TOCSY, CCH-TOCSY, and 3D 13C-HSQC-NOESY. Aromatic ring resonances were assigned from 2D-NOESY using the sample dissolved in 100% D2O. The exchanging amide protons were monitored by dissolving the protein in 100% D2O and acquiring a series of 15N-HSQC spectra. The proton chemical shifts were referenced to the 2,2-dimethylsilapentane-sulfonic acid (DSS) externally. The 15N and 13C chemical shifts were referenced indirectly to DSS. The distance restraints for the structure calculation were collected from 3D 15N-HSQC-NOESY, 13C-HSQC-NOESY, and 2D NOESY in D2O for which CYANA was used.14 Dihedral angle restraints were calculated from chemical shifts using TALOS11 and the overall secondary structure was predicted from the Chemical shift Index15 and NOE pattern. The final 20 energy-minimized structures with the lowest target function energy were selected for further analysis and water refinement was performed using ARIA/CNS.16, 17 The structures were evaluated using the program PROCHECK18 and visualized by MOLMOL.6 The statistics for the NMR structures of the FKBD of PfFKBP35 are summarized in Table I. The eight additional residues (LEHHHHHH) at the C-terminus were not used in the structure calculation. Total observable backbone 1H-15N correlations spanning residues 3–127 were assigned. For the carbon resonances, 126 Cα and 112 Cβ (14 Glycines without Cβ) resonances have been assigned except M1. The unassigned residues are M1, T2, and the C-terminal His tag. Excluding the C-terminal His-tag residues, assignment of the side chains are about 90% complete. The average root-mean-square deviation (RMSD) values relative to the mean coordinate of 20 representative conformers were 0.69 Å for the backbone atoms and 1.12 Å for heavy atoms for residues 7–127, respectively [Table I and Fig. 1(B)]. Like the typical structural folds of the FKBP family proteins,19 the FKBD of PfFKBP35 forms a half β-barrel composed of a six-stranded antiparallel β-sheet and a short central α-helix [Fig. 1(C)]: β1 (20–24); β2 (39–48); β3 (53–54); β4 (65–67); β5 (90–95); β6 (116–126), and α1 (76-83). A search for protein structures with folds similar to the FKBD of PfFKBP35 was performed using the DALI server,20 revealing 11 candidates with Z-scores above 2. The closest structural homology of the FKBD is FKBP12 (PDB ID 1FKR)5 with the highest Z-score of 10 and RMSD of 2.6 Å for the entire FKBD domain. The overall folds are similar to a backbone RMSD 1.50 Å between the averaged, energy-minimized NMR structures of FKBP12 (PDB ID: 1FKS) and the FKBD (residues 18–26, 38–53, 72–101, and 111–125). The active site pocket resembles that of FKB12 as expected from the conserved residues featured by aromatic characteristics (F. W, Y) and involved in binding FK506. Difference was observed in the regions of β3/4 and β5/6 loops [Fig. 1(C–E)]. There is a concentration of positive potential in β3/4 loop of FKBP12, while in the FKBD of PfFKBP35 the positive charged residues (R41 and K45 in FKBP12) in the region are changed to F58 and V62. The amino acid residue differences found in β3/4 loops [Fig. 1(A)] could be attributed to different topologies of active site entrances [Fig. 1(E)]. Previous studies indicated that PfFKBP35 shows FK506-binding and PPIase activities similar to those of canonical FKBP family members,2, 3 but its calcineurin-inhibitory activity appears to be different.4 These suggest that the structural difference seen in the loop regions of the FKBD of PfFKBP35 might contribute to determining specificity of PfFKBP35 among the FKBP family, since those loops are also involved in its ligand-binding and enzymatic function. The structural information obtained from this study may aid in designing potential antimalarial drugs. The NMR resonance assignments were deposited in the BMRB data bank (BMRB: 15038) and the structure was deposited in the PDB bank (PDB ID: 2OFN).